AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsSign up free
🇰🇪

Palbociclib in Kenya

8 products registered with PPB — 8 active

Brand / ProductReg. No.HolderStatusExpires
PALBOCARE 125
Capsule, Hard
H2026/CTD11012/23863Javia International Limitedactive25 Mar 2031
PALCLIB 100
Capsule
H2026/CTD13190/28003MSN LABORATORIES PRIVATE LIMITED (Formulation…active19 Jan 2031
PALCLIB 125
Capsule
H2026/CTD13189/28004MSN LABORATORIES PRIVATE LIMITED (Formulation…active19 Jan 2031
PALBIS 100
Capsule
H2026/CTD12934/26735M/s. Hetero Labs Limitedactive18 Jan 2031
PALBIS 125
Capsule
H2026/CTD12394/26740M/s. Hetero Labs Limitedactive18 Jan 2031
Ibrance 100 mg Tablets
Tablet
H2025/CTD11113/22133Pfizer Laboratories Limited, Kenyaactive27 Jul 2030
Ibrance 75 mg Tablets
Tablet
H2025/CTD11117/22131Pfizer Laboratories Limited, Kenyaactive27 Jul 2030
Ibrance 125 mg Tablets
Tablet
H2025/CTD11116/22132Pfizer Laboratories Limited, Kenyaactive27 Jul 2030

Palbociclib — PPB Registration Details

PPB (Kenya) has 8 registered products containing Palbociclib, of which 8 are currently active. Data is sourced directly from the official PPB drug register and refreshed daily.

Track Palbociclib registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.